{"entity":{"type":"insider","cik":"0001585018","url":"/insider/0001585018","json_url":"/insider/0001585018.json","name":"Hesslein Robert W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":29,"first":"2014-07-09","last":"2023-03-22","span_basis":"filed_date"},"name_variants":[{"name":"Hesslein Robert W.","source":"filing","n_filings":29,"first_seen":"2014-07-09","last_seen":"2023-03-22"}],"transactions":[{"id":8072692,"accession":"0001104659-23-035638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-035638","line_url":"/filing/0001104659-23-035638#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4410.0,"shares_display":"4,410","price_per_share":7.76,"price_display":"7.76","price_state":"stated","total_value":34221.6,"total_display":"34,221.60","total_whole":"34,222","shares_owned_after":102200.0,"shares_owned_after_display":"102,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-22","scope":"insider"},{"id":8357013,"accession":"0001104659-23-024424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-024424","line_url":"/filing/0001104659-23-024424#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3297.0,"shares_display":"3,297","price_per_share":7.45,"price_display":"7.45","price_state":"stated","total_value":24562.65,"total_display":"24,562.65","total_whole":"24,563","shares_owned_after":106610.0,"shares_owned_after_display":"106,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-22","scope":"insider"},{"id":8533592,"accession":"0001104659-23-022429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-022429","line_url":"/filing/0001104659-23-022429#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2868.0,"shares_display":"2,868","price_per_share":7.67,"price_display":"7.67","price_state":"stated","total_value":21997.56,"total_display":"21,997.56","total_whole":"21,998","shares_owned_after":109907.0,"shares_owned_after_display":"109,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":8468310,"accession":"0001104659-23-005053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-005053","line_url":"/filing/0001104659-23-005053","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2188.0,"shares_display":"2,188","price_per_share":9.84872029250457,"price_display":"9.85","price_state":"stated","total_value":21549.0,"total_display":"21,549.00","total_whole":"21,549","shares_owned_after":113567.0,"shares_owned_after_display":"113,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":2},{"id":6519889,"accession":"0001104659-22-043244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-043244","line_url":"/filing/0001104659-22-043244#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2786.0,"shares_display":"2,786","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":22984.5,"total_display":"22,984.50","total_whole":"22,985","shares_owned_after":114963.0,"shares_owned_after_display":"114,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-06","scope":"insider"},{"id":6124683,"accession":"0001104659-22-037153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-037153","line_url":"/filing/0001104659-22-037153","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4955.0,"shares_display":"4,955","price_per_share":8.294565085771948,"price_display":"8.29","price_state":"stated","total_value":41099.57,"total_display":"41,099.57","total_whole":"41,100","shares_owned_after":117807.0,"shares_owned_after_display":"117,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-23","scope":"insider","n_lines":2},{"id":6397546,"accession":"0001104659-22-025672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-025672","line_url":"/filing/0001104659-22-025672#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":3.55,"price_display":"3.55","price_state":"stated","total_value":14555.0,"total_display":"14,555.00","total_whole":"14,555","shares_owned_after":122704.0,"shares_owned_after_display":"122,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-22","scope":"insider"},{"id":6695964,"accession":"0001104659-22-023834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-023834","line_url":"/filing/0001104659-22-023834#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3252.0,"shares_display":"3,252","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":10926.72,"total_display":"10,926.72","total_whole":"10,927","shares_owned_after":126804.0,"shares_owned_after_display":"126,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-15","scope":"insider"},{"id":4584018,"accession":"0001104659-21-047689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-047689","line_url":"/filing/0001104659-21-047689#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3292.0,"shares_display":"3,292","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":16295.4,"total_display":"16,295.40","total_whole":"16,295","shares_owned_after":110056.0,"shares_owned_after_display":"110,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider"},{"id":4281504,"accession":"0001104659-21-023939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-023939","line_url":"/filing/0001104659-21-023939#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3186.0,"shares_display":"3,186","price_per_share":7.55,"price_display":"7.55","price_state":"stated","total_value":24054.3,"total_display":"24,054.30","total_whole":"24,054","shares_owned_after":49348.0,"shares_owned_after_display":"49,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":3130304,"accession":"0001104659-20-044247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-044247","line_url":"/filing/0001104659-20-044247#line-1","is_derivative":false,"issuer_cik":"0001585018","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585018","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (Senior VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Senior VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3091.0,"shares_display":"3,091","price_per_share":8.51,"price_display":"8.51","price_state":"stated","total_value":26304.41,"total_display":"26,304.41","total_whole":"26,304","shares_owned_after":52534.0,"shares_owned_after_display":"52,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-03","filed_date":"2020-04-07","scope":"insider"},{"id":6078988,"accession":"0001209191-18-041550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-041550","line_url":"/filing/0001209191-18-041550#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2520.0,"shares_display":"2,520","price_per_share":136.66,"price_display":"136.66","price_state":"stated","total_value":344383.2,"total_display":"344,383.20","total_whole":"344,383","shares_owned_after":105203.0,"shares_owned_after_display":"105,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-05","scope":"insider"},{"id":6420976,"accession":"0001209191-18-022887","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-022887","line_url":"/filing/0001209191-18-022887#line-3","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1585.0,"shares_display":"1,585","price_per_share":74.88,"price_display":"74.88","price_state":"stated","total_value":118684.8,"total_display":"118,684.80","total_whole":"118,685","shares_owned_after":107723.0,"shares_owned_after_display":"107,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-03","scope":"insider"},{"id":6286125,"accession":"0001209191-18-004227","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-004227","line_url":"/filing/0001209191-18-004227#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18021.0,"shares_display":"18,021","price_per_share":64.3,"price_display":"64.30","price_state":"stated","total_value":1158750.3,"total_display":"1,158,750.30","total_whole":"1,158,750","shares_owned_after":98343.0,"shares_owned_after_display":"98,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":6253661,"accession":"0001209191-18-001127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-001127","line_url":"/filing/0001209191-18-001127","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1864.0,"shares_display":"1,864","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":119296.0,"total_display":"119,296.00","total_whole":"119,296","shares_owned_after":116836.0,"shares_owned_after_display":"116,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider","n_lines":2},{"id":4542471,"accession":"0001209191-17-055736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-055736","line_url":"/filing/0001209191-17-055736","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2165.0,"shares_display":"2,165","price_per_share":38.8,"price_display":"38.80","price_state":"stated","total_value":84002.0,"total_display":"84,002.00","total_whole":"84,002","shares_owned_after":118891.0,"shares_owned_after_display":"118,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider","n_lines":2},{"id":4162766,"accession":"0001209191-17-044355","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-044355","line_url":"/filing/0001209191-17-044355","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5070.0,"shares_display":"5,070","price_per_share":38.84,"price_display":"38.84","price_state":"stated","total_value":196918.8,"total_display":"196,918.80","total_whole":"196,919","shares_owned_after":122091.0,"shares_owned_after_display":"122,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-06","filed_date":"2017-07-07","scope":"insider","n_lines":3},{"id":4445596,"accession":"0001209191-17-032611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-032611","line_url":"/filing/0001209191-17-032611#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1009.0,"shares_display":"1,009","price_per_share":33.87,"price_display":"33.87","price_state":"stated","total_value":34174.83,"total_display":"34,174.83","total_whole":"34,175","shares_owned_after":118430.0,"shares_owned_after_display":"118,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-12","filed_date":"2017-05-16","scope":"insider"},{"id":4903960,"accession":"0001209191-17-025573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-025573","line_url":"/filing/0001209191-17-025573#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1233.0,"shares_display":"1,233","price_per_share":31.96,"price_display":"31.96","price_state":"stated","total_value":39406.68,"total_display":"39,406.68","total_whole":"39,407","shares_owned_after":103072.0,"shares_owned_after_display":"103,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":4829897,"accession":"0001209191-17-021681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021681","line_url":"/filing/0001209191-17-021681#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6231.0,"shares_display":"6,231","price_per_share":31.67,"price_display":"31.67","price_state":"stated","total_value":197335.77,"total_display":"197,335.77","total_whole":"197,336","shares_owned_after":104305.0,"shares_owned_after_display":"104,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-20","scope":"insider"},{"id":5154742,"accession":"0001209191-17-001962","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-001962","line_url":"/filing/0001209191-17-001962#line-2","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1426.0,"shares_display":"1,426","price_per_share":18.49,"price_display":"18.49","price_state":"stated","total_value":26366.74,"total_display":"26,366.74","total_whole":"26,367","shares_owned_after":110536.0,"shares_owned_after_display":"110,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-05","scope":"insider"},{"id":5154735,"accession":"0001209191-17-001962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-001962","line_url":"/filing/0001209191-17-001962#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3256.0,"shares_display":"3,256","price_per_share":17.41,"price_display":"17.41","price_state":"stated","total_value":56686.96,"total_display":"56,686.96","total_whole":"56,687","shares_owned_after":111962.0,"shares_owned_after_display":"111,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":2256360,"accession":"0001209191-16-144869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-144869","line_url":"/filing/0001209191-16-144869#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1220.0,"shares_display":"1,220","price_per_share":23.65,"price_display":"23.65","price_state":"stated","total_value":28853.0,"total_display":"28,853.00","total_whole":"28,853","shares_owned_after":115218.0,"shares_owned_after_display":"115,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-04","filed_date":"2016-10-05","scope":"insider"},{"id":2886772,"accession":"0001209191-16-131506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-131506","line_url":"/filing/0001209191-16-131506#line-2","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":18.26,"price_display":"18.26","price_state":"stated","total_value":23190.2,"total_display":"23,190.20","total_whole":"23,190","shares_owned_after":107061.0,"shares_owned_after_display":"107,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-06","scope":"insider"},{"id":2886770,"accession":"0001209191-16-131506","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-131506","line_url":"/filing/0001209191-16-131506#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3435.0,"shares_display":"3,435","price_per_share":17.39,"price_display":"17.39","price_state":"stated","total_value":59734.65,"total_display":"59,734.65","total_whole":"59,735","shares_owned_after":108331.0,"shares_owned_after_display":"108,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":8937940,"accession":"0001209191-15-024532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-024532","line_url":"/filing/0001209191-15-024532#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4635.0,"shares_display":"4,635","price_per_share":47.24,"price_display":"47.24","price_state":"stated","total_value":218957.4,"total_display":"218,957.40","total_whole":"218,957","shares_owned_after":68125.0,"shares_owned_after_display":"68,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-10","scope":"insider"},{"id":8825440,"accession":"0001209191-15-022207","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-022207","line_url":"/filing/0001209191-15-022207#line-3","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1424.0,"shares_display":"1,424","price_per_share":48.35,"price_display":"48.35","price_state":"stated","total_value":68850.4,"total_display":"68,850.40","total_whole":"68,850","shares_owned_after":72760.0,"shares_owned_after_display":"72,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"},{"id":8932758,"accession":"0001209191-15-004185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-004185","line_url":"/filing/0001209191-15-004185#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":52.1116,"price_display":"52.11","price_state":"stated","total_value":364781.2,"total_display":"364,781.20","total_whole":"364,781","shares_owned_after":60125.0,"shares_owned_after_display":"60,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-14","scope":"insider"},{"id":8845270,"accession":"0001209191-15-003651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-003651","line_url":"/filing/0001209191-15-003651#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":23.0329,"price_display":"23.03","price_state":"stated","total_value":92131.6,"total_display":"92,131.60","total_whole":"92,132","shares_owned_after":67125.0,"shares_owned_after_display":"67,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":6768838,"accession":"0001209191-14-064147","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-064147","line_url":"/filing/0001209191-14-064147","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":23.18325,"price_display":"23.18","price_state":"stated","total_value":92733.0,"total_display":"92,733.00","total_whole":"92,733","shares_owned_after":72425.0,"shares_owned_after_display":"72,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-17","filed_date":"2014-10-21","scope":"insider","n_lines":3},{"id":6321922,"accession":"0001209191-14-046523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-046523","line_url":"/filing/0001209191-14-046523#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585018","owner_name":"Hesslein Robert W.","owner_display_name":"Hesslein Robert W.","owner_url":"/insider/0001585018","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":27.2237,"price_display":"27.22","price_state":"stated","total_value":108894.8,"total_display":"108,894.80","total_whole":"108,895","shares_owned_after":75125.0,"shares_owned_after_display":"75,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-08","filed_date":"2014-07-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":39,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640266","name":"Voyager Therapeutics, Inc.","url":"/issuer/0001640266","role":"Officer (Senior VP & General Counsel)","n_filings":11,"first_seen":"2020-04-07","last_seen":"2023-03-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001488613","name":"Foundation Medicine, Inc.","url":"/issuer/0001488613","role":"Officer (SVP and General Counsel)","n_filings":18,"first_seen":"2014-07-09","last_seen":"2018-07-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001585018","retrieved_at":"2026-08-22T13:25:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}